Merck KGaA (OTCMKTS:MKKGY) Short Interest Update

Merck KGaA (OTCMKTS:MKKGY) was the target of a significant growth in short interest in September. As of September 15th, there was short interest totaling 3,461 shares, a growth of 95.4% from the August 31st total of 1,771 shares. Based on an average daily volume of 323,326 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are sold short.

Merck KGaA Stock Performance

OTCMKTS:MKKGY traded up $0.06 during mid-day trading on Wednesday, reaching $31.37. The company’s stock had a trading volume of 24,853 shares, compared to its average volume of 97,951. Merck KGaA has a 12-month low of $23.73 and a 12-month high of $34.19. The firm’s fifty day moving average price is $31.84 and its two-hundred day moving average price is $29.79. The company has a current ratio of 1.69, a quick ratio of 1.09 and a debt-to-equity ratio of 0.37. The stock has a market cap of $20.27 billion, a P/E ratio of 16.17, a PEG ratio of 2.99 and a beta of 0.96.

Analysts Set New Price Targets

A number of analysts have recently commented on MKKGY shares. HSBC raised Merck KGaA to a “hold” rating in a research report on Monday, July 6th. Zacks Research downgraded Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. Finally, UBS Group cut Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 20th. Six analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Merck KGaA Company Profile

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. The company operates independently from Merck & Co, Inc, the U.S.-based company that uses the Merck name in the United States and Canada.

Merck KGaA operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, analytical technologies and bioprocessing solutions used by pharmaceutical and biotechnology companies, academic institutions and industrial laboratories.